Pricing Log in Create free account
Saturday 17 October 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

ResMed Inc. (RMD) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Aug 31, 2026 8.01 Other events
8-K Aug 13, 2026 4.01 Change in the certifying accountant; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Auditor change Officer departure
10-K Jun 30, 2026 1: 12 added · 16 removed · 84 modified
1A: 15 added · 7 removed · 80 modified
7: 11 added · 9 removed · 38 modified
8-K Aug 6, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jun 30, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026 P1I2: 5 added · 1 removed · 27 modified
P2I1A: no material changes, the filing says
8-K Apr 24, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Apr 30, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Dec 31, 2025
8-K Jan 29, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Nov 19, 2025 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 30, 2025 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-K Jun 30, 2025
10-Q Mar 31, 2025

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.